These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 1405328)
1. Effect of dialyzer geometry during hemodialysis with cuprophane membranes. Taylor JE; McLaren M; Mactier RA; Henderson IS; Stewart WK; Belch JJ Kidney Int; 1992 Aug; 42(2):442-7. PubMed ID: 1405328 [TBL] [Abstract][Full Text] [Related]
2. Patient reactions and granulocyte degranulation during hemodialysis with cuprophane and polycarbonate membranes. A double-blind study. Danielson BG; Hällgren R; Venge P Blood Purif; 1986; 4(1-3):147-50. PubMed ID: 3524607 [TBL] [Abstract][Full Text] [Related]
3. Effect of erythropoietin therapy and withdrawal on blood coagulation and fibrinolysis in hemodialysis patients. Taylor JE; Belch JJ; McLaren M; Henderson IS; Stewart WK Kidney Int; 1993 Jul; 44(1):182-90. PubMed ID: 8355460 [TBL] [Abstract][Full Text] [Related]
4. Hemodialysis-associated platelet loss: study of the relative contribution of dialyzer membrane composition and geometry. Docci D; Turci F; Del Vecchio C; Bilancioni R; Cenciotti L; Pretolani E Int J Artif Organs; 1984 Nov; 7(6):337-40. PubMed ID: 6526528 [TBL] [Abstract][Full Text] [Related]
5. The influence of dialyzer geometry on blood coagulation and biocompatibility. Lins LE; Boberg U; Jacobson SH; Kjellstrand C; Ljungberg B; Skröder R Clin Nephrol; 1993 Nov; 40(5):281-5. PubMed ID: 8281717 [TBL] [Abstract][Full Text] [Related]
6. Effect of dialyzer geometry on granulocyte and complement activation. Schaefer RM; Heidland A; Hörl WH Am J Nephrol; 1987; 7(2):121-6. PubMed ID: 3496792 [TBL] [Abstract][Full Text] [Related]
7. [Changes in leukocyte counts using a cellulose acetate membrane (FB-T) during hemodialysis. A comparison with a cuprophane membrane]. Pak K; Kobira S; Tomoyoshi T; Nishimura N Hinyokika Kiyo; 1986 Sep; 32(9):1231-5. PubMed ID: 3812143 [TBL] [Abstract][Full Text] [Related]
8. Intradialytic body weight changes and dialyzer pore size as main contributing factors to the evolution of beta-2-microglobulin in dialysis. Vanholder RC; Ringoir SM Blood Purif; 1990; 8(1):32-44. PubMed ID: 2198890 [TBL] [Abstract][Full Text] [Related]
9. Soluble P-selectin during a single hemodialysis session in patients with chronic renal failure and erythropoietin treatment. Stasko J; Galajda P; Ivanková J; Hollý P; Rozborilová E; Kubisz P Clin Appl Thromb Hemost; 2007 Oct; 13(4):410-5. PubMed ID: 17911193 [TBL] [Abstract][Full Text] [Related]
10. Hemodialysis-associated platelet activation and thrombocytopenia. Hakim RM; Schafer AI Am J Med; 1985 Apr; 78(4):575-80. PubMed ID: 3885730 [TBL] [Abstract][Full Text] [Related]
12. [Beneficial effect of AN69 membranes on anemia in hemodialyzed patients]. García Cortés MJ; Sánchez Perales MC; Liébana A; Gil JM; Borrego FJ; Borrego J; Pérez del Barrio P; Serrano P; Pérez Bañasco V Nefrologia; 2001; 21(4):370-5. PubMed ID: 11816513 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of platelets and hemostasis during hemodialysis with six different membranes. Verbeelen D; Jochmans K; Herman AG; Van der Niepen P; Sennesael J; De Waele M Nephron; 1991; 59(4):567-72. PubMed ID: 1766495 [TBL] [Abstract][Full Text] [Related]
14. Influence of acetate and bicarbonate hemodialysis on the plasma erythropoietin concentration in patients with chronic renal failure. Wiecek A; Franek E; Kokot F; Rudka R Int J Artif Organs; 1997 Feb; 20(2):108-11. PubMed ID: 9093890 [TBL] [Abstract][Full Text] [Related]
15. [Effect of hemodialysis with cuprophane and polysulfone membranes on counts of leukocytes, granulocytes, monocytes, lymphocytes and lymphocyte subsets]. Moczulski D; Zukowska-Szczechowska E; Grzeszczak W; Religa Z; Cichoń R; Szydłowska I Pol Arch Med Wewn; 1994 Nov; 92(5):400-7. PubMed ID: 7885988 [TBL] [Abstract][Full Text] [Related]
16. Granulocyte activation and adhesion molecules during hemodialysis with cuprophane and a high-flux biocompatible membrane. Combe C; Pourtein M; de Précigout V; Baquey A; Morel D; Potaux L; Vincendeau P; Bézian JH; Aparicio M Am J Kidney Dis; 1994 Sep; 24(3):437-42. PubMed ID: 8079969 [TBL] [Abstract][Full Text] [Related]
17. The effect of dialyser membrane material on intradialytic changes in platelet count, platelet aggregation, circulating platelet aggregates and antithrombin III. Knudsen F; Nielsen AH; Kristensen SD Scand J Urol Nephrol; 1985; 19(3):227-32. PubMed ID: 4070991 [TBL] [Abstract][Full Text] [Related]
18. Increases in circulating level of platelet-activating factor lag behind transient neutropenia during hemodialysis with cuprophane membranes. Sakaguchi K; Morimoto S; Chen YH; Nakamoto Y; Ogihara T Nephron; 1991; 59(3):455-60. PubMed ID: 1758537 [TBL] [Abstract][Full Text] [Related]
19. Citrate anticoagulation does not correct cuprophane bioincompatibility as evaluated by the expression of leukocyte surface molecules. Dhondt A; Vanholder R; Waterloos MA; Glorieux G; De Smet R; Lameire N Nephrol Dial Transplant; 1998 Jul; 13(7):1752-8. PubMed ID: 9681723 [TBL] [Abstract][Full Text] [Related]
20. Leucocyte occlusion of cuprophane membranes as a cause of reduced hemodialysis efficiency. Dodd NJ; Parsons V; Weston MJ Int J Artif Organs; 1982 Jul; 5(4):275-6. PubMed ID: 7118290 [No Abstract] [Full Text] [Related] [Next] [New Search]